 Gregory Way
Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 7 | 2022 | 528 | 2.290 |
Why?
| | Machine Learning | 7 | 2022 | 318 | 1.900 |
Why?
| | Microscopy | 4 | 2023 | 125 | 1.380 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2023 | 694 | 1.220 |
Why?
| | Transcriptome | 3 | 2019 | 741 | 0.920 |
Why?
| | Software | 3 | 2023 | 531 | 0.910 |
Why?
| | Gene Expression Profiling | 7 | 2022 | 1547 | 0.900 |
Why?
| | Aggression | 3 | 2015 | 186 | 0.890 |
Why?
| | Molecular Imaging | 1 | 2023 | 51 | 0.880 |
Why?
| | Polypharmacology | 1 | 2022 | 1 | 0.820 |
Why?
| | Cells | 1 | 2021 | 21 | 0.750 |
Why?
| | Neurofibromin 1 | 2 | 2019 | 22 | 0.750 |
Why?
| | Data Compression | 1 | 2020 | 8 | 0.720 |
Why?
| | Forecasting | 1 | 2021 | 332 | 0.670 |
Why?
| | Neoplasms | 5 | 2020 | 2112 | 0.660 |
Why?
| | ras Proteins | 2 | 2019 | 137 | 0.620 |
Why?
| | Glioblastoma | 2 | 2019 | 251 | 0.620 |
Why?
| | Single-Cell Analysis | 1 | 2018 | 180 | 0.580 |
Why?
| | Gene Silencing | 2 | 2018 | 176 | 0.580 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2016 | 44 | 0.550 |
Why?
| | Ovarian Neoplasms | 3 | 2018 | 407 | 0.540 |
Why?
| | Gene Expression | 2 | 2021 | 1442 | 0.530 |
Why?
| | Behavior, Animal | 3 | 2015 | 471 | 0.520 |
Why?
| | Genetic Association Studies | 1 | 2016 | 351 | 0.490 |
Why?
| | Genome-Wide Association Study | 2 | 2021 | 1301 | 0.490 |
Why?
| | Zebrafish | 2 | 2015 | 412 | 0.480 |
Why?
| | Personality | 1 | 2015 | 115 | 0.450 |
Why?
| | Algorithms | 6 | 2022 | 1493 | 0.450 |
Why?
| | Models, Biological | 1 | 2020 | 1647 | 0.430 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 1891 | 0.420 |
Why?
| | Cell Line, Tumor | 6 | 2023 | 2749 | 0.400 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1143 | 0.300 |
Why?
| | Databases, Genetic | 2 | 2018 | 200 | 0.270 |
Why?
| | Humans | 22 | 2023 | 115900 | 0.270 |
Why?
| | Genome, Human | 2 | 2018 | 374 | 0.260 |
Why?
| | Phenotype | 3 | 2022 | 2858 | 0.260 |
Why?
| | Quantitative Trait Loci | 2 | 2024 | 322 | 0.240 |
Why?
| | Bortezomib | 1 | 2023 | 41 | 0.230 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 40 | 0.230 |
Why?
| | Cell Line | 2 | 2021 | 2655 | 0.230 |
Why?
| | Boronic Acids | 1 | 2023 | 33 | 0.220 |
Why?
| | Pyrazines | 1 | 2023 | 70 | 0.220 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 136 | 0.220 |
Why?
| | Signal Transduction | 4 | 2019 | 4525 | 0.210 |
Why?
| | Neuroblastoma | 2 | 2020 | 130 | 0.210 |
Why?
| | High-Throughput Screening Assays | 1 | 2023 | 123 | 0.200 |
Why?
| | Budgets | 1 | 2021 | 14 | 0.200 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 183 | 0.200 |
Why?
| | Interdisciplinary Research | 1 | 2021 | 25 | 0.200 |
Why?
| | Publications | 1 | 2021 | 37 | 0.190 |
Why?
| | Cell Culture Techniques | 1 | 2023 | 346 | 0.190 |
Why?
| | Bone Development | 1 | 2021 | 48 | 0.190 |
Why?
| | Biological Assay | 1 | 2021 | 114 | 0.180 |
Why?
| | N-Myc Proto-Oncogene Protein | 1 | 2020 | 7 | 0.180 |
Why?
| | Supervised Machine Learning | 1 | 2020 | 11 | 0.180 |
Why?
| | Reproducibility of Results | 3 | 2017 | 2814 | 0.180 |
Why?
| | Bone Diseases | 1 | 2021 | 58 | 0.180 |
Why?
| | Mentoring | 1 | 2021 | 103 | 0.170 |
Why?
| | Reward | 1 | 2021 | 208 | 0.170 |
Why?
| | Epigenomics | 1 | 2020 | 106 | 0.170 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 638 | 0.170 |
Why?
| | Cooperative Behavior | 1 | 2021 | 390 | 0.160 |
Why?
| | Information Dissemination | 1 | 2021 | 192 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2019 | 448 | 0.160 |
Why?
| | Multiple Myeloma | 1 | 2019 | 93 | 0.160 |
Why?
| | Recombinational DNA Repair | 1 | 2018 | 9 | 0.160 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 8 | 0.150 |
Why?
| | Atlases as Topic | 1 | 2018 | 9 | 0.150 |
Why?
| | Bone and Bones | 1 | 2021 | 283 | 0.150 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 125 | 0.150 |
Why?
| | Immunity, Cellular | 1 | 2019 | 263 | 0.150 |
Why?
| | Acid Phosphatase | 1 | 2017 | 18 | 0.150 |
Why?
| | Bone Density | 2 | 2021 | 432 | 0.150 |
Why?
| | Phosphoproteins | 1 | 2019 | 302 | 0.150 |
Why?
| | Biomedical Technology | 1 | 2018 | 41 | 0.150 |
Why?
| | Systems Biology | 1 | 2018 | 56 | 0.150 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2017 | 69 | 0.150 |
Why?
| | Motivation | 1 | 2021 | 496 | 0.150 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2017 | 78 | 0.150 |
Why?
| | GTPase-Activating Proteins | 1 | 2017 | 72 | 0.150 |
Why?
| | Proteomics | 2 | 2021 | 854 | 0.150 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 703 | 0.140 |
Why?
| | Nonlinear Dynamics | 1 | 2018 | 89 | 0.140 |
Why?
| | Bayes Theorem | 1 | 2018 | 336 | 0.140 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 424 | 0.140 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 269 | 0.130 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 233 | 0.130 |
Why?
| | Cichlids | 1 | 2015 | 3 | 0.130 |
Why?
| | Neoplasm Grading | 1 | 2016 | 244 | 0.130 |
Why?
| | Genetic Loci | 1 | 2017 | 280 | 0.130 |
Why?
| | Cluster Analysis | 1 | 2016 | 466 | 0.130 |
Why?
| | Animals | 5 | 2023 | 32121 | 0.120 |
Why?
| | Models, Genetic | 1 | 2018 | 584 | 0.120 |
Why?
| | Apoptosis | 1 | 2023 | 2377 | 0.120 |
Why?
| | Video Recording | 1 | 2015 | 147 | 0.120 |
Why?
| | DNA Methylation | 1 | 2017 | 498 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2209 | 0.100 |
Why?
| | Biomedical Research | 1 | 2018 | 590 | 0.100 |
Why?
| | Brain Neoplasms | 1 | 2019 | 979 | 0.100 |
Why?
| | Chromosome Mapping | 2 | 2024 | 502 | 0.100 |
Why?
| | Female | 7 | 2021 | 60081 | 0.090 |
Why?
| | Sex Characteristics | 1 | 2015 | 644 | 0.090 |
Why?
| | Molecular Sequence Annotation | 2 | 2019 | 74 | 0.080 |
Why?
| | Child | 3 | 2021 | 18556 | 0.070 |
Why?
| | Chromatin | 2 | 2021 | 427 | 0.070 |
Why?
| | Male | 5 | 2021 | 56126 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2017 | 1870 | 0.070 |
Why?
| | Genomics | 2 | 2021 | 641 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2021 | 1129 | 0.060 |
Why?
| | Mutation | 3 | 2019 | 3369 | 0.060 |
Why?
| | Cell Shape | 1 | 2024 | 54 | 0.060 |
Why?
| | Mutant Proteins | 1 | 2024 | 96 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2024 | 554 | 0.050 |
Why?
| | Gene Editing | 1 | 2021 | 62 | 0.040 |
Why?
| | Osteoblasts | 1 | 2021 | 106 | 0.040 |
Why?
| | Antigens, CD20 | 1 | 2019 | 28 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 132 | 0.040 |
Why?
| | Rhabdomyosarcoma | 1 | 2019 | 52 | 0.040 |
Why?
| | Osteosarcoma | 1 | 2019 | 67 | 0.040 |
Why?
| | Sarcoma, Ewing | 1 | 2019 | 63 | 0.040 |
Why?
| | Osteogenesis | 1 | 2021 | 184 | 0.040 |
Why?
| | Wilms Tumor | 1 | 2019 | 66 | 0.040 |
Why?
| | Adult | 1 | 2020 | 30817 | 0.040 |
Why?
| | Genes, Neoplasm | 1 | 2018 | 21 | 0.040 |
Why?
| | Loss of Heterozygosity | 1 | 2018 | 41 | 0.040 |
Why?
| | Gene Ontology | 1 | 2018 | 45 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 275 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2018 | 111 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 365 | 0.040 |
Why?
| | Disease | 1 | 2018 | 83 | 0.040 |
Why?
| | CpG Islands | 1 | 2017 | 123 | 0.040 |
Why?
| | Drug Design | 1 | 2018 | 156 | 0.040 |
Why?
| | Wnt Proteins | 1 | 2018 | 135 | 0.040 |
Why?
| | Terminology as Topic | 1 | 2018 | 190 | 0.040 |
Why?
| | Recurrence | 1 | 2019 | 949 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2017 | 157 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2021 | 594 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2018 | 332 | 0.030 |
Why?
| | Precision Medicine | 1 | 2019 | 356 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2018 | 286 | 0.030 |
Why?
| | DNA Damage | 1 | 2018 | 356 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2018 | 754 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2018 | 447 | 0.030 |
Why?
| | Sexual Behavior, Animal | 1 | 2015 | 49 | 0.030 |
Why?
| | Histones | 1 | 2020 | 539 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 945 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1177 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 788 | 0.030 |
Why?
| | Computer Simulation | 1 | 2018 | 887 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 531 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2022 | 0.030 |
Why?
| | Decision Making | 1 | 2018 | 792 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2018 | 801 | 0.020 |
Why?
| | Delivery of Health Care | 1 | 2018 | 847 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4449 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3583 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9176 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10517 | 0.020 |
Why?
| | Mice | 1 | 2019 | 15073 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 17956 | 0.010 |
Why?
|
|
Way's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|